Counselors in Northbridge, MA Accepting Medicare

4 Counselors found. Showing 1 - 4

Mrs. Barbara Alteri Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2355 Providence Road, Healing Center Building, Northbridge, MA 01534 Phone: 508-843-0469

Brenda Michelle Wilson Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 229 Pollard Rd, Northbridge, MA 01534 Phone: 508-479-8588

Katherine Ware Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 76 Church Ave, Northbridge, MA 01534 Phone: 508-234-4181

Elizabeth Bolt Counselor Medicare: Not Enrolled in Medicare Practice Location: 43 Sutton St, Apartment B, Northbridge, MA 01534 Phone: 774-327-5160

News Archive

CMSC's educational conference provides up-to-date information on multiple sclerosis

The Consortium of Multiple Sclerosis Centers (CMSC), the leading member-driven North American organization dedicated to improving and advancing the standards of healthcare and clinical research for those living with MS, announces that registration is open for its 32nd Annual Meeting.

Phase 3 U.S. registration study of LODOTRA shows improvement in patients with RA

Horizon Pharma, Inc., announced today that data from the Phase 3 U.S. registration study of LODOTRA, a circadian cytokine modulator and novel modified-release, low-dose prednisone tablet, showed a statistically significant improvement in American College of Rheumatology response criteria in patients with rheumatoid arthritis.

Life-saving bone marrow transplants may also cure peanut allergies

Not only can bone marrow transplants be life-saving for children with acute lymphocytic leukemia, they may also cure peanut allergies. According to research presented during the American College of Allergy, Asthma and Immunology's Annual Scientific Meeting, a 10-year-old boy no longer had a peanut allergy after undergoing a bone marrow transplant.

Scientists shed new light on why pancreatic cancer drugs can fail

Cancer Research UK scientists led an international team of investigators who have discovered a new mechanism that may explain why pancreatic cancer patients are often resistant to a common chemotherapy treatment called gemcitabine, according to a study published in Science.

Tigris Pharmaceuticals begins enrollment in AFP-464 Phase 2 trial in ER-positive breast cancer

Tigris Pharmaceuticals, Inc., today announced enrollment of its first patient in a randomized Phase 2 clinical trial of AFP-464 with or without Faslodex in estrogen receptor (ER)-positive breast cancer patients.

Read more Medical News

› Verified 7 days ago